The global outlook series on Biotechnology provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a bird’s eye view of the Biotechnology industry. Annotated with 26 fact, and data rich tables presenting analytical segmentation by product application, the report provides global revenues, and expenditure on R&D of/by biotechnology companies, sales of enabling technologies, biologic drug sales by product and global biotech/pharmacogenomics/bioinformatics product/technology sales, among others. The report offers a sneak peek into major end-use industries, taking note of select trends in Genomics, Biochips, Biologics and Biopharmaceutical Intermediates, Biogenerics, Biotechnology Instruments, and Biotechnology Reagents, among others. Also included is a compilation of all recent mergers, acquisitions, and strategic corporate developments. A regional-level of discussion mirrors the prevalent scenario in key regional markets such as the US, Canada, Mexico, Japan, France, Germany, Poland, UK, Sweden, Switzerland, New Zealand, India, Malaysia, and Brazil, among few others. The report also includes an indexed, easy-to-refer, fact-finder directory listing the addresses, and contact details of 2,220 companies worldwide.